Moris Demetrios, Vernadakis Spyridon, Papalampros Alexandros, Vailas Michail, Dimitrokallis Nikolaos, Petrou Athanasios, Dimitroulis Dimitrios
Demetrios Moris, Department of Immunology, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH 44195, United States.
World J Gastroenterol. 2016 Sep 7;22(33):7613-24. doi: 10.3748/wjg.v22.i33.7613.
To highlight the potential mechanisms of regeneration in the Associating Liver Partition and Portal vein ligation for Stage hepatectomy models (clinical and experimental) that could unlock the myth behind the extraordinary capability of the liver for regeneration, which would help in designing new therapeutic options for the regenerative drive in difficult setup, such as chronic liver diseases. Associating Liver Partition and Portal vein ligation for Stage hepatectomy has been recently advocated to induce rapid future liver remnant hypertrophy that significantly shortens the time for the second stage hepatectomy. The introduction of Associating Liver Partition and Portal vein ligation for Stage hepatectomy in the surgical armamentarium of therapeutic tools for liver surgeons represented a real breakthrough in the history of liver surgery.
A comprehensive literature review of Associating Liver Partition and Portal vein ligation for Stage hepatectomy and its utility in liver regeneration is performed.
Liver regeneration after Associating Liver Partition and Portal vein ligation for Stage hepatectomy is a combination of portal flow changes and parenchymal transection that generate a systematic response inducing hepatocyte proliferation and remodeling.
Associating Liver Partition and Portal vein ligation for Stage hepatectomy represents a real breakthrough in the history of liver surgery because it offers rapid liver regeneration potential that facilitate resection of liver tumors that were previously though unresectable. The jury is still out though in terms of safety, efficacy and oncological outcomes. As far as Associating Liver Partition and Portal vein ligation for Stage hepatectomy -induced liver regeneration is concerned, further research on the field should focus on the role of non-parenchymal cells in liver regeneration as well as on the effect of Associating Liver Partition and Portal vein ligation for Stage hepatectomy in liver regeneration in the setup of parenchymal liver disease.
强调联合肝脏分隔和门静脉结扎分期肝切除术模型(临床和实验)中的再生潜在机制,这些机制可能揭开肝脏非凡再生能力背后的谜团,这将有助于设计针对诸如慢性肝病等困难情况下再生驱动的新治疗方案。联合肝脏分隔和门静脉结扎分期肝切除术最近被提倡用于诱导未来肝脏残体快速肥大,从而显著缩短二期肝切除术的时间。联合肝脏分隔和门静脉结扎分期肝切除术引入肝脏外科医生的治疗工具库中,代表了肝脏手术史上的一次真正突破。
对联合肝脏分隔和门静脉结扎分期肝切除术及其在肝脏再生中的效用进行全面的文献综述。
联合肝脏分隔和门静脉结扎分期肝切除术后的肝脏再生是门静脉血流变化和实质横断的结合,产生一种系统性反应,诱导肝细胞增殖和重塑。
联合肝脏分隔和门静脉结扎分期肝切除术代表了肝脏手术史上的一次真正突破,因为它具有快速肝脏再生潜力,有助于切除以前被认为无法切除的肝脏肿瘤。不过,在安全性、有效性和肿瘤学结果方面,尚无定论。就联合肝脏分隔和门静脉结扎分期肝切除术诱导的肝脏再生而言,该领域的进一步研究应聚焦于非实质细胞在肝脏再生中的作用,以及联合肝脏分隔和门静脉结扎分期肝切除术在实质性肝病情况下对肝脏再生的影响。